![]() |
Name |
Penispirozine A
|
Molecular Formula | C20H20N2O8S | |
IUPAC Name* |
(1S,8S,9R,12R,13R)-9,13-dihydroxy-4-[(2-hydroxy-3,4-dimethoxyphenyl)methylidene]-7-oxa-15-thia-3,6-diazatetracyclo[10.2.1.01,6.08,13]pentadec-10-ene-2,5-dione
|
|
SMILES |
COC1=C(C(=C(C=C1)C=C2C(=O)N3[C@]4(C[C@@]5([C@H](S4)C=C[C@H]([C@@H]5O3)O)O)C(=O)N2)O)OC
|
|
InChI |
InChI=1S/C20H20N2O8S/c1-28-12-5-3-9(14(24)15(12)29-2)7-10-17(25)22-20(18(26)21-10)8-19(27)13(31-20)6-4-11(23)16(19)30-22/h3-7,11,13,16,23-24,27H,8H2,1-2H3,(H,21,26)/t11-,13-,16+,19+,20+/m1/s1
|
|
InChIKey |
HHVBNMJIUHMSJK-JKRAONCPSA-N
|
|
Synonyms |
Penispirozine A
|
|
CAS | NA | |
PubChem CID | 156580830 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 448.4 | ALogp: | 0.0 |
HBD: | 4 | HBA: | 9 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 163.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 31 | QED Weighted: | 0.38 |
Caco-2 Permeability: | -5.279 | MDCK Permeability: | 0.00000893 |
Pgp-inhibitor: | 0.088 | Pgp-substrate: | 0.019 |
Human Intestinal Absorption (HIA): | 0.688 | 20% Bioavailability (F20%): | 0.793 |
30% Bioavailability (F30%): | 0.94 |
Blood-Brain-Barrier Penetration (BBB): | 0.967 | Plasma Protein Binding (PPB): | 92.01% |
Volume Distribution (VD): | 0.926 | Fu: | 2.86% |
CYP1A2-inhibitor: | 0.028 | CYP1A2-substrate: | 0.952 |
CYP2C19-inhibitor: | 0.027 | CYP2C19-substrate: | 0.736 |
CYP2C9-inhibitor: | 0.038 | CYP2C9-substrate: | 0.767 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.218 |
CYP3A4-inhibitor: | 0.353 | CYP3A4-substrate: | 0.907 |
Clearance (CL): | 3.404 | Half-life (T1/2): | 0.684 |
hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.444 |
Drug-inuced Liver Injury (DILI): | 0.981 | AMES Toxicity: | 0.708 |
Rat Oral Acute Toxicity: | 0.725 | Maximum Recommended Daily Dose: | 0.025 |
Skin Sensitization: | 0.171 | Carcinogencity: | 0.759 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.433 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004278 | ![]() |
0.660 | D03DIG | ![]() |
0.284 | ||
ENC004279 | ![]() |
0.660 | D06GCK | ![]() |
0.270 | ||
ENC004280 | ![]() |
0.598 | D0L1JW | ![]() |
0.258 | ||
ENC004281 | ![]() |
0.598 | D07MGA | ![]() |
0.246 | ||
ENC003738 | ![]() |
0.589 | D01XWG | ![]() |
0.243 | ||
ENC003659 | ![]() |
0.553 | D04TDQ | ![]() |
0.239 | ||
ENC004282 | ![]() |
0.531 | D07VLY | ![]() |
0.239 | ||
ENC004283 | ![]() |
0.531 | D0C9XJ | ![]() |
0.239 | ||
ENC003545 | ![]() |
0.475 | D06TQZ | ![]() |
0.238 | ||
ENC006030 | ![]() |
0.475 | D0WE3O | ![]() |
0.237 |